IME Share Price Performance
Recent IME News & Updates
No updates
Imagin Medical Inc. Key Details
Last Reported Earnings
Jun 30, 2023
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.31
- Gross Margin
- 0%
- Net Profit Margin
- 0%
- Debt/Equity Ratio
- -91.8%
Imagin Medical Inc. Competitors
About IME
- Founded
- 1986
- Employees
- n/a
- CEO
- WebsiteView website
Imagin Medical Inc., a urologic oncology company, focuses on the research, development, and commercialization of medical devices in the bio-chemistry industry. It offers the i/Blue Imaging System, which detects bladder cancer with advanced proprietary optics and light sensors; and enCage Coil, a disposable and focal therapy precision ablation device for use in the treatment of prostate cancer. The company is also developing technologies to visualize and treat urologic cancers through minimally invasive surgery, including bladder and prostate cancer. It has a license agreement with Lawrence Livermore National Security, LLC to develop and commercialize the i/Blue Imaging System. The company was founded in 1986 and is headquartered in Vancouver, Canada.
Canadian Market Performance
- 7 Days: -0.5%
- 3 Months: 10.1%
- 1 Year: 15.6%
- Year to Date: 10.0%
Over the last 7 days, the market has remained flat, although notably the Materials sector declined by 4.2%. More promisingly, the market is up 16% over the past year. As for the next few years, earnings are expected to grow by 12% per annum. Market details ›
Companies across the globe are beginning to pay attention to agentic AI. It’s also a term you’re likely to hear a lot during earnings season. In fact, it came up 26 times during...
Continue reading